OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
November 02, 2023
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
October 12, 2023
The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.
September 06, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
August 23, 2023
WuXi XDC will provide end-to-end services to support Boostimmune’s discovery of novel bioconjugates.
May 24, 2023
The facility is based on a state-of-the-art design concept that allows maximum flexibility for a multi-product, multi-platform offering.
May 09, 2023
The new portfolio from the acquisition will include contract research organization solutions, contract development and manufacturing organization solutions, and KSM/API solutions.
April 02, 2023
Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.
February 22, 2023
Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.
February 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.